US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist
  • 2.365
  • -0.015-0.63%
Trading Feb 26 11:16 ET
174.14MMarket Cap-15.77P/E (TTM)

Protalix Biotherapeutics Key Stats

Protalix Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.600M--
--2024/Q4-- / 18.746M--
Nov 14, 20242024/Q317.839M / 16.258M--
Aug 14, 20242024/Q213.304M / 12.500M--
May 10, 20242024/Q13.677M / 9.200M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.600M--
--2024/Q4-- / 18.746M--
Nov 14, 20242024/Q317.839M / 16.258M--
Aug 14, 20242024/Q213.304M / 12.500M--
May 10, 20242024/Q13.677M / 9.200M--

Unlock Free Earnings Estimates

Protalix Biotherapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 3, 2025

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data